Table 2.
Protein class | Protein | Effect in depression models | Effect in addiction models |
---|---|---|---|
Transcription factor | CREB | ↑ Susceptibility | ↓ Drug reward |
NFκB | ↑ Susceptibility | ↑ Drug reward | |
ΔFosB | ↓ Susceptibility | ↑ Drug reward | |
SRF | ↓ Susceptibility | 0 Drug reward | |
β-catenin2 | ↓ Susceptibility | N/A | |
Signaling | BDNF-TrkB | ↑ Susceptibility | ↑ or ↓ Cocaine reward1, ↓ Morphine reward |
GluA2 | ↓ Susceptibility | ↑ Drug reward | |
RGS4 | ↓ Susceptibility3 | ↓ Drug reward | |
Rac1 | ↓ Susceptibility | ↓ Drug reward | |
Dynorphin | ↑ Susceptibility | ↓ Drug reward | |
Epigenetic | HDAC (Class I) inhibition | ↓ Susceptibility | ↑ Drug reward4 |
HDAC55 | ↓ Susceptibility | ↓ Drug reward | |
G9a inhibition | ↑ Susceptibility | ↑ Drug reward | |
DNMT inhibition | ↓ Susceptibility | ↑ Drug reward |
The influence of BDNF-TrkB signaling in NAc on cocaine reward is opposite in D1-type versus D2-type medium spiny neurons, although the net effect is to promote reward18.
The influence of β-catenin is derived from studies of upstream proteins (e.g., disheveled and glycogen synthase kinase 3β)131.
From164.
While short-term inhibition drives increased reward, longer-term inhibition does the opposite165.
A class II HDAC.